AKT1 and cholangiocarcinoma: Since AKT is activated by CK2 [32] and AKT inhibitors are effective in vitro against CCA [5], we tested the combination of MK2206/CX4945, demonstrating, at least in mucin- and mixed-IHCCA, additive effects on apoptosis.